October 3rd, 2019 Xstrahl and Washington DC-based C&C Irradiator Service are announcing a partnership to supply next generation X-ray irradiator systems to replace cesium sources across the U.S. Used throughout the world, with hundreds in the United States,...
Dosimety radiobiology experiemtns have long needed a viable and realistic mouse phantom. In their paper “Technical Note: Manufacturing of a realistic mouse phantom for dosimetry of radiobiology experiments.” Esplen N, Alyaqoub E & Bazalova-Carter M aim to design a...
In their paper “Characterization of a plastic scintillating detector for the Small Animal Radiation Research Platform (SARRP)” Johnstone CD, Therriault-Proulx F, Beaulieu L & Bazalova-Carter M aimed to characterize a small plastic scintillator developed for high...
September 13th, 2019 New X-ray radiotherapy image guidance system and SARRP beamline research platform among advanced new solutions showcased on Xstrahl booth (No. 4028) at American Society for Radiation Oncology annual meeting in Chicago, September 15th-18th....
Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized radiosensitizer that enhances the tumoricidal effects of radiation. Most preclinical in vivo HT studies use subcutaneous tumor models which do not adequately...
Xstrahl would like to say a big thank you to all the participants of the SARRP User Meeting hosted by the Xstrahl Life Sciences team on August 25th, 2019, the first day of the ICRR 2019 conference. The SARRP User Meeting brought together SARRP scientists from Europe...
Side effects caused by radiation are a limiting factor to the amount of dose that can be applied to a tumor volume. A novel method to reduce side effects in radiotherapy is the use of spatial fractionation, in which a pattern of sub-millimeter beams (minibeams) is...
Glioblastoma (GB) is the most common primary malignant brain tumor in adults. The standard of care consists of maximal possible surgical resection with concomitant radiation therapy (RT) and temozolomide (TMZ). Currently the target volume delineation for RT is based...
Xstrahl would like to invite you to explore several new treatment and preclinical research advancements at the annual ASTRO meeting on September 15th-18th in Chicago. Xstrahl is launching a new image-guidance system, a sleek and streamlined way of giving clinicians a...
Contact Us